Roots Analysis has
announced the addition of Clinical Trial Planning and Design Services
Market report
to its list of offerings.
During our research, we
were able to identify 46 industry players that are engaged in offering clinical
trial planning and design services. The clinical trial planning and design
services domain is presently dominated by the presence of large firms (70%),
followed by mid-sized companies (18%). most of the players engaged in this
domain offer study design / protocol development (96%), followed by those
providing sample size and power analysis services (83%). Notable examples of
players offering more than four services include (in alphabetical order),
Cancer Research And Biostatistics (1997), Peter MacCallum Cancer Centre (1949),
Singapore Clinical Research Institute (2008) and University of
Arizona College of Medicine (2006).
To request a sample copy / brochure of this
report, please visit this – https://www.rootsanalysis.com/reports/clinical-trial-planning-and-design-services-market/request-sample.html
Over the years, clinical
research has undergone an evolutionary change, in terms of cost of research,
technology used, and duration of the study. Clinical research involves a
thorough literature review that helps to collate information on studies that
involve interactions with patients and diagnostic clinical trial data, in order
to understand the root cause of a disease and its treatment. It is worth
highlighting that clinical research involves two major steps, namely study
design and study reporting. Further, study design involves three key steps,
theoretical design, data collection design and statistical analysis design.
Specifically, experimental or non-experimental data collection, sampling or
census data collection, and temporal characteristics of the variables to be
examined are all aspects of data collection design. On the other hand, study
reporting includes guiding principles to carry out concise, explicit and
elaborative research.
§ Planning
Period: This parameter takes into consideration the
time period that is required to draw up the protocol, as well as to define the
objectives of the trial. It is worth highlighting that the period for planning
a clinical trial can take up to a year.
§ Duration
of a Trial: It takes into consideration the amount of
time required to recruit participants, as well as to monitor their reaction and
survival rate.
§ Comparability
of Patients: It takes into consideration the
comparability of enrolled patient population with respect to prognostic
factors. It is worth mentioning that prognostic factors define the enrolled
patient population, help to formulate the objectives of the trial, and provide
better treatment strategies. These factors provide valid estimates of the
differences in the given treatment and help to evaluate results across
different studies.
§ Treatment
Allocation Ratio: This step helps to reduce bias, balanced
comparison between two treatment groups and quantification of errors. It is
worth highlighting that patients can be allocated to two different trials at
the same time; however, in such cases, patients are usually allocated randomly
in a 60:40 or 2:1 ratio.
§ Use
of Historical Control Group: Historical control group can be used to
estimate model parameters during the research design phase, to modify a study,
or to augment or replace a control arm. Most of the clinical trials include a control group of patients
who have the same characteristics as the specially treated group; however,
these patients are not administered with the drug / therapy treatment.
§ Treatment
Management: The treatment provided to enrolled patients
should be administered equally, regardless of their treatment plan. Further, in
each therapy group, patients should have the same criteria of response and
toxicity.
§ Ethical
Considerations: Ethical concerns can arise at any point
throughout the trial. It is worth mentioning that conditions under which a
patient may be withdrawn from the study should be carefully examined, prior to
the trial. Further, an international review board must approve all
human-related research projects.
To
request a free insight to this report - https://www.rootsanalysis.com/reports/clinical-trial-planning-and-design-services-market/free-insights.html
Key Questions Answered
- Who are the key players engaged in
offering clinical trial planning and design services, across the world?
- What are the regulatory guidelines
established in different geographies and their requirements related to
clinical trial planning and design?
- What kind of partnership models
are most commonly adopted by stakeholders engaged in this industry?
- What are the key value drivers of
the merger and acquisition activity observed within this domain?
- How is the current and future
market opportunity likely to be distributed across key market segments?
- What are the anticipated future
trends related to clinical trial planning and design services?
For
additional details, please visit - https://www.rootsanalysis.com/reports/clinical-trial-planning-and-design-services-market.html Or [email protected]
Roots Analysis is one of the fastest growing market
research companies, sharing fresh and independent perspectives in the
bio-pharmaceutical industry. The in-depth research, analysis and insights are
driven by an experienced leadership team which has gained many years of
significant experience in this sector. If you’d like help with your growing
business needs, get in touch at [email protected]
Contact
Details
Ben
Johnson
+1
(415) 800 3415
Roots
Analysis
Web: https://www.rootsanalysis.com/
LinkedIn: https://in.linkedin.com/company/roots-analysis
Twitter: https://twitter.com/RootsAnalysis.com
Medium: https://medium.com/@RootsAnalysis
Pinterest: https://in.pinterest.com/RootsanalysisPin/_saved/
Quora: https://rootsanalysisinsights.quora.com/
